Joel L Nitzkin | OMICS International
ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 2464

Journal of Addiction Research & Therapy received 2464 citations as per Google Scholar report

Journal of Addiction Research & Therapy peer review process verified at publons
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • SafetyLit
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Joel L Nitzkin

Tobacco Policy, R Street Institute, New Orleans, Louisiana, USA


Joel L  Nitzkin is a versatile author and has contributed major research works in the field of Addiction Research and Therapy, psychology, and neurology. And has dedicated their major research contributions in the field of Addiction research, Substance-Related Disorders, Psychology, Neurology, Behavioural Science, etc.

E-Cig Tipping Points vs. FDA Deeming Regulations

E-cigarettes and related vapor products (e-cigs) are here to stay. They have tipped from a fad to a permanent part of the tobacco product scene. They now constitute a ten year old multibillion dollar industry in the United States. More likely than not, they offer personal and public health benefits far exceeding theoretically plausible harms. The c... Read More»

Joel L Nitzkin

Commentary: J Addict Res Ther 2016, 7:304

DOI: 10.4172/2155-6105.1000304

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article